Smithkline Beecham Corporation
Records under this name other than the patents Smithkline Beecham Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Smithkline Beecham Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,282,588 | Azaindole Inhibitors of Aurora Kinases Formerly held In force · High confidence | In force | High confidence | |
| US 7,419,988 | Azaindole Inhibitors of Aurora Kinases Formerly held In force · High confidence | In force | High confidence | |
| US 7,495,102 | Azaindole Inhibitors of Aurora Kinases Formerly held In force · High confidence | In force | High confidence | |
| US 7,605,266 | Azaindole Inhibitors of Aurora Kinases Formerly held In force · High confidence | In force | High confidence | |
| US 8,158,665 | Farnesoid X Receptor Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 7,838,540 | 3-Aminocarbonyl, 6-Phenyl Substituted PYRIDINE-1-Oxides as P38 Kinase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 7,705,028 | Farnesoid X Receptor Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 8,026,262 | Chemical Compounds Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,572,820 | Chemical Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 7,897,330 | Methods for Characterizing Enzyme Inhibitors Formerly held In force · High confidence | In force | High confidence |